1 Zhao YZ, "Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo" 38 : 1090-1098, 2012
2 Zhou S, "Ultrasoundtargeted microbubble destruction mediated herpes simplex virusthymidine kinase gene treats hepatoma in mice" 29 : 170-, 2010
3 Boissenot T, "Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems:from theoretical considerations to practical applications" 241 : 144-163, 2016
4 Carson AR, "Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy" 72 : 6191-6199, 2012
5 Chen H, "Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors" 1 : 10-, 2013
6 Bekeredjian R, "Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart" 108 : 1022-1026, 2003
7 Yu BF, "Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma" 20 : 290-297, 2013
8 Panje CM, "Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency" 2 : 1078-1091, 2012
9 Schoellhammer CM, "Ultrasound-mediated gastrointestinal drug delivery" 7 : 310ra168-, 2015
10 Mullick Chowdhury S, "Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs" 238 : 272-280, 2016
11 Wang TY, "Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer" 203 : 99-108, 2015
12 Li P, "Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice" 162 : 349-354, 2012
13 Abou-Elkacem L, "Ultrasound molecular imaging: moving toward clinical translation" 84 : 1685-1693, 2015
14 Anderson CR, "Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent" 46 : 215-224, 2011
15 Fokong S, "Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics" 53 : 345-348, 2012
16 Ferrara K, "Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery" 9 : 415-447, 2007
17 Azagury A, "Ultrasound effect on dancerous versus non-cancerous cells" 42 : 1560-1567, 2016
18 Panje CM, "Ultrasound and microbubblemediated gene delivery in cancer: progress and perspectives" 48 : 755-769, 2013
19 Tzu-Yin W, "Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications" 14 : 743-752, 2013
20 Jürgen K. Willmann, "Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results" American Society of Clinical Oncology (ASCO) 35 (35): 2133-2140, 2017
21 de Jong N, "Ultrasonic characterization of ultrasound contrast agents" 47 : 861-873, 2009
22 Deshpande N, "Tumor angiogenic marker expression levels during tumor growth:longitudinal assessment with molecularly targeted microbubbles and US imaging" 258 : 804-811, 2011
23 Kotopoulis S, "Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study" 40 : 072902-, 2013
24 Bouakaz A, "Therapeutic ultrasound" Springer 175-189, 2016
25 Escoffre JM, "Therapeutic ultrasound" Springer 243-261, 2016
26 Rapoport N, "Therapeutic ultrasound" Springer 221-241, 2016
27 Bettinger T, "Therapeutic ultrasound" Springer 191-204, 2016
28 Tartis MS, "Therapeutic effects of paclitaxel-containing ultrasound contrast agents" 32 : 1771-1780, 2006
29 Unger EC, "Therapeutic applications of lipid-coated microbubbles" 56 : 1291-1314, 2004
30 Tsutsui JM, "The use of microbubbles to target drug delivery" 2 : 23-, 2004
31 Husseini GA, "The role of cavitation in acoustically activated drug delivery" 107 : 253-261, 2005
32 Pysz MA, "Targeted contrast-enhanced ultrasound:an emerging technology in abdominal and pelvic imaging" 140 : 785-790, 2011
33 Willmann JK, "Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides" 51 : 433-440, 2010
34 Sirsi SR, "State-of-the-art materials for ultrasoundtriggered drug delivery" 72 : 3-14, 2014
35 Delalande A, "Sonoporation: mechanistic insights and ongoing challenges for gene transfer" 525 : 191-199, 2013
36 Kotopoulis S, "Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft" 16 : 53-62, 2014
37 Zhou Y, "Principles and applications of therapeutic ultrasound in healthcare" CRC Press 2015
38 Paris JL, "Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers" 9 : 11023-11033, 2015
39 Devulapally R, "Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy" 9 : 2290-2302, 2015
40 Salgaonkar VA, "Passive cavitation imaging with ultrasound arrays" 126 : 3071-3083, 2009
41 Coviello C, "Passive acoustic mapping utilizing optimal beamforming in ultrasound therapy monitoring" 137 : 2573-2585, 2015
42 Yan F, "Paclitaxel-liposomemicrobubble complexes as ultrasound-triggered therapeutic drug delivery carriers" 166 : 246-255, 2013
43 Chomas JE, "Optical observation of contrast agent destruction" 77 : 1056-1058, 2000
44 Simonin JP, "On the mechanisms of in vitro and in vivo phonophoresis" 33 : 125-141, 1995
45 Lv Y, "Novel multifunctional pHsensitive nanoparticles loaded into microbubbles as drug delivery vehicles for enhanced tumor targeting" 6 : 29321-, 2016
46 Tinkov S, "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" 148 : 368-372, 2010
47 Morch Y, "Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery" 10 : 356-366, 2015
48 Lee JY, "Nanoparticle-loaded protein-polymer nanodroplets for improved stability and conversion efficiency in ultrasound imaging and drug delivery" 27 : 5484-5492, 2015
49 Shapiro G, "Multiparameter evaluation of in vivo gene delivery using ultrasound-guided, microbubble-enhanced sonoporation" 223 : 157-164, 2016
50 Deshpande N, "Molecular ultrasound imaging: current status and future directions" 65 : 567-581, 2010
51 Pysz MA, "Molecular imaging: current status and emerging strategies" 65 : 500-516, 2010
52 Willmann JK, "Molecular imaging in drug development" 7 : 591-607, 2008
53 Kircher MF, "Molecular body imaging: MR imaging, CT, and US. Part II. Applications" 264 : 349-368, 2012
54 Kircher MF, "Molecular body imaging: MR imaging, CT, and US. Part I. principles" 263 : 633-643, 2012
55 Hernot S, "Microbubbles in ultrasound-triggered drug and gene delivery" 60 : 1153-1166, 2008
56 Unnikrishnan S, "Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application" 199 : 292-299, 2012
57 Sorace AG, "Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer" 20 : 43-54, 2012
58 Vignon F, "Microbubble cavitation imaging" 60 : 661-670, 2013
59 Kondo T, "Low-intensity ultrasound adjuvant therapy: enhancement of doxorubicin-induced cytotoxicity and the acoustic mechanisms involved" 36 : 61-, 2009
60 Unger EC, "Local drug and gene delivery through microbubbles" 44 : 45-54, 2001
61 Huang SL, "Liposomes in ultrasonic drug and gene delivery" 60 : 1167-1176, 2008
62 Barnett SB, "International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine" 26 : 355-366, 2000
63 Quinto-Su PA, "Interaction between two laser-induced cavitation bubbles in a quasi-two-dimensional geometry" 633 : 425-435, 2009
64 Sonoda S, "Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization" 6 : 1276-1283, 2007
65 Treat LH, "Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma" 38 : 1716-1725, 2012
66 Mitragotri S, "Healing sound: the use of ultrasound in drug delivery and other therapeutic applications" 4 : 255-260, 2005
67 Devulapally R, "Gemcitabine and antisense-microRNA co-encapsulated PLGA-PEG polymer nanoparticles for hepatocellular carcinoma therapy" 8 : 33412-33422, 2016
68 Apfel RE, "Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound" 17 : 179-185, 1991
69 Carlisle R, "Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound" 105 : 1701-1710, 2013
70 Bai M, "Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound" 6 : 43779-43790, 2015
71 Zhu F, "Effectiveness of localized ultrasoundtargeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model" 23 : 323-334, 2015
72 Arora M, "Effect of nuclei concentration on cavitation cluster dynamics" 121 : 3432-3436, 2007
73 Bachawal SV, "Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model" 73 : 1689-1698, 2013
74 Lentacker I, "Drug loaded microbubble design for ultrasound triggered delivery" 5 : 2161-2170, 2009
75 Cochran MC, "Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model" 18 : 1341-1348, 2011
76 Caskey CF, "Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall" 122 : 1191-1200, 2007
77 Tun MT, "Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts" 12 : 15-, 2012
78 Foygel K, "Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1" 145 : 885-894, 2013
79 Guan L, "Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities" 14 : 153-, 2016
80 Borden MA, "DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles" 23 : 9401-9408, 2007
81 Liu HL, "Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview" 4 : 432-444, 2014
82 Blake JR, "Cavitation bubbles near boundaries" 19 : 99-123, 1987
83 Lauterborn W, "Cavitation bubble dynamics" 4 : 65-75, 1997
84 Wang DS, "Cationic versus neutral microbubbles for ultrasoundmediated gene delivery in cancer" 264 : 721-732, 2012
85 Mukundakrishnan K, "Bubble motion in a blood vessel: shear stress induced endothelial cell injury" 131 : 074516-, 2009
86 Liu HL, "Bloodbrain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment" 255 : 415-425, 2010
87 Helfield B, "Biophysical insight into mechanisms of sonoporation" 113 : 9983-9988, 2016
88 Kang J, "Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasoundtargeted microbubble activation on VX2 rabbit liver tumors" 29 : 61-70, 2010
89 Pysz MA, "Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55)" 256 : 519-527, 2010
90 Nie F, "Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in vivo experimental study" 16 : 389-395, 2008
91 Tang H, "An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport" 19 : 1160-1169, 2002
92 Unger EC, "Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent" 33 : 886-892, 1998
93 Wilson KE, "Acoustic and photoacoustic molecular imaging of cancer" 54 : 1851-1854, 2013
94 Wang XL, "A novel plasmid and SonoVue formulation plus ultrasound sonication for effective gene delivery in nude mice" 93 : 536-542, 2013
95 Duan L, "A multi-gradient targeting drug delivery system based on RGD-L-TRAIL-labeled magnetic microbubbles for cancer theranostics" 26 : 8313-8324, 2016
96 Dimcevski G, "A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer" 243 : 172-181, 2016